Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial
- PMID: 10650316
- DOI: 10.1067/mhj.2000.103743
Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical